Solstein Capital’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-489
Closed -$21K 300
2022
Q3
$21K Hold
489
0.02% 194
2022
Q2
$21K Hold
489
0.02% 224
2022
Q1
$21K Hold
489
0.01% 251
2021
Q4
$26K Hold
489
0.02% 264
2021
Q3
$23K Hold
489
0.01% 291
2021
Q2
$22K Hold
489
0.03% 276
2021
Q1
$21K Buy
+489
New +$20.3K 0.03% 249
2020
Q4
Sell
-489
Closed -$19K 133
2020
Q3
$19K Hold
489
0.04% 179
2020
Q2
$18K Hold
489
0.04% 176
2020
Q1
$14K Hold
489
0.05% 174
2019
Q4
$21K Buy
+489
New +$19.5K 0.04% 181

Other funds holding G

Solstein Capital's G Position: Q4 2022 in Review

Solstein Capital sold out of Genpact (G) in Q4 2022, closing a stake of 489 shares — an estimated $21K sold.

Solstein Capital first reported a position in G in Q4 2019 and held it in 11 quarters. The position peaked at $26K in Q4 2021. 371 funds tracked by Wall St. Rank hold G as of Q4 2022.

  • Solstein Capital reported no remaining Genpact position as of Q4 2022 after selling out during the quarter.
  • Solstein Capital sold 489 Genpact shares in Q4 2022, an estimated $21K.
  • Solstein Capital first reported a position in Genpact in Q4 2019 and held it in 11 quarters.
  • Solstein Capital's Genpact position peaked at $26K in Q4 2021.
  • 371 funds tracked by Wall St. Rank held Genpact as of Q4 2022.

Based on Solstein Capital's 13F filing for Q4 2022, filed 2 Feb 2023.